Hanla IMS Co., Ltd. (KOSDAQ:092460)
15,550
+380 (2.50%)
At close: Apr 10, 2026
Hanla IMS Revenue
In the year 2025, Hanla IMS had annual revenue of 133.48B KRW with 28.05% growth. Hanla IMS had revenue of 39.59B in the quarter ending December 31, 2025, with 22.69% growth.
Revenue
133.48B
Revenue Growth
+28.05%
P/S Ratio
1.90
Revenue / Employee
647.95M
Employees
206
Market Cap
254.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 133.48B | 29.24B | 28.05% |
| Dec 31, 2024 | 104.24B | 25.29B | 32.04% |
| Dec 31, 2023 | 78.94B | -19.69B | -19.96% |
| Dec 31, 2022 | 98.64B | 42.12B | 74.52% |
| Dec 31, 2021 | 56.52B | 2.23B | 4.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewon Sanup | 1.06T |
| Elentec | 753.16B |
| Mirai Semiconductors | 478.59B |
| DongWon Development | 387.34B |
| Iljin Power | 251.98B |
| Ubiquoss Holdings | 155.66B |
| CMG Pharmaceutical | 105.23B |
| SG Co.,Ltd | 102.25B |